Serveur d'exploration sur Pittsburgh - Analysis (Canada)

Index « Auteurs » - entrée « Sylvain Baruchel »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Sylvain Auclair < Sylvain Baruchel < Sylvain Giroux  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 2.
Ident.Authors (with country if any)Title
000377 (2013) Judy L. Felgenhauer [États-Unis] ; Michael L. Nieder [États-Unis] ; Mark D. Krailo [États-Unis] ; Mark L. Bernstein [Canada] ; David W. Henry [États-Unis] ; David Malkin [Canada] ; Sylvain Baruchel [Canada] ; Paul J. Chuba [États-Unis] ; Scott L. Sailer [États-Unis] ; Ken Brown [Canada] ; Sarangarajan Ranganathan [États-Unis] ; Neyssa Marina [États-Unis]A pilot study of low‐dose anti‐angiogenic chemotherapy in combination with standard multiagent chemotherapy for patients with newly diagnosed metastatic Ewing sarcoma family of tumors: A Children's Oncology Group (COG) Phase II study NCT00061893
000572 (2012) Eric Bouffet [Canada] ; Regina Jakacki [États-Unis] ; Stewart Goldman [États-Unis] ; Darren Hargrave [Royaume-Uni] ; Cynthia Hawkins [Canada] ; Manohar Shroff [Canada] ; Juliette Hukin [Canada, États-Unis] ; Ute Bartels [Canada] ; Nicholas Foreman [États-Unis] ; Stewart Kellie [Australie] ; Joanne Hilden [États-Unis] ; Michael Etzl [États-Unis] ; Beverly Wilson [Canada] ; Derek Stephens [Canada] ; Uri Tabori [Canada] ; Sylvain Baruchel [Canada]Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma

List of associated KwdEn.i

Nombre de
documents
Descripteur
2Vinblastine
1Administration schedule
1Antineoplastic agent
1Apparent clearance
1Apparent volume
1Bone bone marrow
1Cancerology
1Cardiac
1Cardiac toxicity
1Cardiovascular risk
1Celecoxib
1Chemotherapy
1Child
1Clin
1Clin cancer
1Clin oncol
1Clin pharmacol
1Clinical trial
1Cmax cmin
1Cumulative incidence
1Cyclophosphamide
1Cystitis
1Death rate
1Disease progression
1Dos
1Drug administration
1Eligible patients
1Ewing
1Ewing sarcoma
1Familial adenomatous polyposis
1Glioma
1Half life
1Hemorrhagic
1Hemorrhagic cystitis
1Higher doses
1Historical controls
1Induction chemotherapy cycles
1Local control
1Local therapy
1Low grade
1Maximum dose
1Maximum plasma concentration
1Median
1Metastasis
1Metastatic
1Metastatic disease
1Metastatic ewing sarcoma
1Metastatic ewing sarcoma family
1Minimum plasma concentration
1Oncol
1Oncology
1Oncology group
1Pediatr
1Pediatr blood cancer
1Pediatric patients
1Pediatrics
1Pharmacokinetic
1Phase II trial
1Pneumonitis
1Preoperative radiation
1Primary lesions
1Primary site
1Primitive neuroectodermal tumor
1Protocol
1Protocol therapy
1Pulmonary irradiation
1Pulmonary metastases
1Pulmonary toxicity
1Radiation pneumonitis
1Radiation therapy
1Relapse
1Sarcoma
1Sick children
1Standard chemotherapy
1Standard deviation
1Standard multiagent chemotherapy
1Statistical analysis
1Supplemental appendix
1Time curve
1Toxicity
1Treatment
1Treatment resistance
1Tumor vasculature
1Unusual toxicities
1Whole lung irradiation
1Wiley periodicals

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Canada/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i -k "Sylvain Baruchel" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Canada/Analysis/Author.i  \
                -Sk "Sylvain Baruchel" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Canada/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Amérique
   |area=    PittsburghV1
   |flux=    Canada
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Sylvain Baruchel
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Fri Jun 18 17:37:45 2021. Site generation: Fri Jun 18 18:15:47 2021